Thomas Malley, Director at Cougar Biotechnology, Inc. (CGRB), bought 19,918 shares at $21.75 ($433K) on 2007-07-17, disclosed to the SEC on 2007-07-20.
Open-market purchase of $433k CGRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.75 | 3,350 | $73K | 16.8% |
| 2 | $21.75 | 8,500 | $185K | 42.7% |
| 3 | $21.75 | 8,068 | $175K | 40.5% |
| Total | $21.75 avg | 19,918 | $433K | 100% |
| Filing → |
| BGNE | BUY | 2016-11-28 | $960K | — | Filing → |
| KURA | BUY | 2015-12-17 | $400K | — | Filing → |
| OVAS | BUY | 2015-04-09 | $143K | — | Filing → |